Active [3H]-dopamine uptake by human lymphocytes: correlates with serotonin transporter activity

Area of Science:

• Neuroscience
• Pharmacology
• Immunology

Background:

• Dopamine and serotonin are crucial neurotransmitters involved in various neurological functions.
• Aberrant neurotransmitter uptake is implicated in psychiatric and addictive disorders.
• Lymphocytes offer a potential peripheral model for studying neurotransmitter transporter function.

Purpose of the Study:

• To investigate whether the uptake of [3H]-dopamine in human lymphocytes is mediated by a serotonin transporter.
• To characterize the affinity of selective serotonin and dopamine/norepinephrine transporter inhibitors for dopamine uptake in lymphocytes.

Main Methods:

• Assessed the effects of various monoamine uptake inhibitors on [3H]-dopamine uptake in human lymphocytes.
• Determined the 50% inhibiting concentration (IC50) for selective serotonin transporter inhibitors (indatraline, imipramine, fluoxetine).
• Determined the IC50 for selective dopamine and norepinephrine transporter inhibitors (bupropion, GBR 12909, nomifensine, xylamine).

Main Results:

• Selective serotonin transporter inhibitors potently inhibited [3H]-dopamine uptake in lymphocytes (IC50: 3.5-17 nmol/l).
• Selective dopamine/norepinephrine transporter inhibitors showed low affinity for lymphocyte dopamine uptake (IC50: 1,000-40,000 nmol/l).
• These results support the involvement of a serotonin transporter in lymphocyte dopamine uptake.

Conclusions:

• Human lymphocyte dopamine uptake is primarily mediated by a serotonin transporter.
• This high-affinity transport system in lymphocytes may serve as a valuable model for studying dopamine and serotonin uptake in neurological conditions.
• Lymphocyte-based models could aid in understanding and detecting changes associated with addictive and psychiatric disorders.